Express News | Verve Therapeutics Inc: Initial Data for Heart-2 Phase 1B Clinical Trial of Verve-102 Targeting Pcsk9 Expected in Q2 of 2025

ReutersJan 13 07:07 ET

Express News | Verve Therapeutics Inc: Well-Capitalized With Cash Runway Extending Into Mid-2027

ReutersJan 13 07:07 ET

Press Release: Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones

Dow JonesJan 13 07:00 ET

Gene Editing Stocks Drop as Intellia Announces Layoffs

Seeking AlphaJan 10 13:29 ET

Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Verve TherapeuticsJan 8 00:00 ET

Verve Therapeutics, Inc. (VERV): Is This Gene Therapy Stock a Good Buy Right Now?

Yahoo FinanceDec 29, 2024 06:34 ET